Skip to main content

Organigram Hlds Inc(OGI-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low1.2650
Day High1.3050
Open:1.2800
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
the globe and mail
the globe and mail

BAT increasing its stake in Organigram with $124.6-million investment

Organigram says the investment will help it extend its footprint beyond Canada and strengthen its financial position for long-term, sustainable growth
Motley Fool
Why Marijuana Stocks Triumphed on Monday
Barchart
3 Cannabis Stocks to Consider Buying as HHS Recommends Easing Restrictions on Marijuana
Motley Fool
Organigram (OGI) Q3 2023 Earnings Call Transcript
GlobeNewswire
Organigram Announces Completion of Share Consolidation
Business Wire
Organigram Reports Second Quarter Fiscal 2023 Results
Motley Fool
Why Tilray Stock Sank and Moved the Canadian Cannabis Market Today
Motley Fool
Which Canadian Cannabis Company Will Be the Next Takeover Target?
Motley Fool
Why Organigram Holdings Stock Is Perking Up Today
Business Wire
Organigram to Report Second Quarter Fiscal 2023 Results on April 11, 2023
Business Wire
Organigram Accelerates Focus on Vapes With Strategic Investment in Greentank
Motley Fool
Why Pot Stocks Are Glowing Green Today
Business Wire
Organigram Announces Director Appointment
Business Wire
Organigram Provides Edison JOLTS Product Update
Motley Fool
3 Top Pot Stocks to Buy Right Now
Business Wire
Organigram Holdings Inc. Announces Election of Directors
Business Wire
Organigram Revolutionizes Hash with SHRED X Rip-Strip Hash
The Canadian Press
Cannabis companies weigh pricing strategies after OCS margin cut
Business Wire
Organigram Provides NASDAQ Listing Update
Motley Fool
3 Cannabis Stocks to Buy and Hold for the Next 10 Years
Motley Fool
Organigram (OGI) Q1 2023 Earnings Call Transcript
Business Wire
Organigram Reports Record First Quarter Fiscal 2023 Results
Business Wire
Organigram to Report First Quarter Fiscal 2023 Results on January 12, 2023
Motley Fool
3 Top Cannabis Stocks to Buy for December
Business Wire
Organigram Wins KIND Magazine’s Cannabis Company of the Year Award and Most Innovative Product of the Year for Edison JOLTS
MarketBeat
MarketBeat: Week in Review 11/28 – 12/02
Motley Fool
OrganiGram Holdings (OGI) Q4 2022 Earnings Call Transcript
MarketBeat
Three Reasons It’s Time To Get Bullish On Organigram
PressReach
New York Issues 36 Licences for Legal Marijuana Dispensaries
Business Wire
Organigram Reports Record Fourth Quarter and Full Year Fiscal 2022 Results
Business Wire
Organigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash Categories
Business Wire
Organigram to Report Annual Fiscal 2022 Results on November 28, 2022
Business Wire
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Profile

Organigram Holdings Inc. is a licensed producer of cannabis and cannabis-derived products primarily in Canada, through a wholly owned subsidiary. Organigram Holdings Inc. is based in Moncton, Canada.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.